David Jorden - Mar 4, 2022 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role
CEO/CFO, Director
Signature
/s/ David Jorden
Stock symbol
AURX
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
4
Date filed
4/26/2022, 09:29 PM
Previous filing
Apr 26, 2022
Next filing
May 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURX Option to Purchase Common Stock Award $0 +66.7K $0.00 66.7K Mar 4, 2022 Common Stock 66.7K $0.50 Direct F1
transaction AURX Option to Purchase Common Stock Award $0 +125K $0.00 125K Mar 4, 2022 Common Stock 125K $0.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in settlement of compensation liability for period January 1, 2019 through April 30, 2019